000 | 01904 a2200529 4500 | ||
---|---|---|---|
005 | 20250517020951.0 | ||
264 | 0 | _c20160328 | |
008 | 201603s 0 0 eng d | ||
022 | _a1745-7254 | ||
024 | 7 |
_a10.1038/aps.2014.147 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZeng, Hong-liang | |
245 | 0 | 0 |
_aYhhu981, a novel compound, stimulates fatty acid oxidation via the activation of AMPK and ameliorates lipid metabolism disorder in ob/ob mice. _h[electronic resource] |
260 |
_bActa pharmacologica Sinica _cMar 2015 |
||
300 |
_a343-52 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAMP-Activated Protein Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aAcetyl-CoA Carboxylase _xmetabolism |
650 | 0 | 4 |
_aAlkynes _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Obesity Agents _xpharmacology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aEnergy Metabolism _xdrug effects |
650 | 0 | 4 | _aEnzyme Activation |
650 | 0 | 4 |
_aEnzyme Activators _xpharmacology |
650 | 0 | 4 |
_aFatty Acids _xmetabolism |
650 | 0 | 4 | _aHep G2 Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLiver _xdrug effects |
650 | 0 | 4 | _aMice, Obese |
650 | 0 | 4 |
_aMuscle Fibers, Skeletal _xdrug effects |
650 | 0 | 4 |
_aObesity _xdrug therapy |
650 | 0 | 4 | _aOxidation-Reduction |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aResorcinols _xpharmacology |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 | _aUp-Regulation |
700 | 1 | _aHuang, Su-ling | |
700 | 1 | _aXie, Fu-chun | |
700 | 1 | _aZeng, Li-min | |
700 | 1 | _aHu, You-hong | |
700 | 1 | _aLeng, Ying | |
773 | 0 |
_tActa pharmacologica Sinica _gvol. 36 _gno. 3 _gp. 343-52 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/aps.2014.147 _zAvailable from publisher's website |
999 |
_c24670656 _d24670656 |